芬兰医护人员对2025/26年新兴流感A(H1N1)pdm09 D.3.1及A(H3N2) K亚分支的中和抗体反应降低
2025年秋季芬兰检测到漂移的A(H3N2) K亚分支及A(H1N1)pdm09 D.3.1和D.3.1.1病毒。研究对46名芬兰医护人员在接种2024/25流感疫苗前后评估针对2024/25疫苗株和2025/26流行A株的抗体反应;该疫苗与2025/26疫苗含相同A(H1N1)pdm09株但A(H3N2)株不同。结果显示对A(H3N2) K亚分支病毒的中和抗体反应显著降低,某些A(H1N1)pdm09株的滴度也降低。
要点
- 2024/25疫苗对新兴A(H3N2) K亚分支的中和抗体反应显著降低。
- 对某些A(H1N1)pdm09株的中和抗体滴度也有所降低。
- 医护人员需关注疫苗株与流行株匹配性对保护力的影响。
核心结论
- 接种2024/25流感疫苗后,医护人员对2025/26新兴A(H3N2) K亚分支和某些A(H1N1)pdm09株的中和抗体反应降低。
研究设计与样本
- 研究纳入46名芬兰医护人员,在接种2024/25流感疫苗前后评估针对2024/25疫苗株和2025/26流行A株的中和抗体反应。
主要发现
- 对A(H3N2) K亚分支病毒的中和抗体反应显著降低。
- 对某些A(H1N1)pdm09株的中和抗体滴度降低。
临床怎么用
- 提示需评估当前疫苗对新兴漂移株的保护效果,并关注医护人员免疫策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During autumn 2025, drifted influenza A(H3N2) subclade K and A(H1N1)pdm09 subclade D.3.1. and D.3.1.1 viruses were detected in Finland. We assessed antibody responses against 2024/25 vaccine and 2025/26 epidemic influenza A strains among 46 Finnish healthcare workers before and after influenza vaccination with the 2024/25 vaccine; this vaccine included identical A(H1N1)pdm09 but different A(H3N2) strains compared with the 2025/26 vaccine. Neutralising antibody responses were markedly reduced against the A(H3N2) subclade K virus and titres for certain A(H1N1)pdm09 strains were reduced.
引用
- Ikonen N, Haveri A, Lindh E, et al. Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025. Euro Surveill. 2026. PMID: 41684323. doi:10.2807/1560-7917.ES.2026.31.6.2600094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。